New imaging study aims to personalize radiation therapy for GEP-NETs
NCT ID NCT06256705
First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 30 times
Summary
This study is looking at people with a rare type of tumor called GEP-NET that has spread and is growing. Participants will get special PET-MRI scans before, during, and after a standard treatment called targeted radiation therapy (PRRT). The goal is to find imaging markers that can predict who will respond best to treatment, helping doctors personalize care in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hépato-gastro-entérologie, cancérologie digestive et assistance nutritionnelle - CHU Nantes
ACTIVE_NOT_RECRUITINGNantes, 44000, France
-
Médecine nucléaire - CHU Nantes
RECRUITINGNantes, 44000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Médecine nucléaire et Biophysique - Beaujon
RECRUITINGClichy, 92110, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Pancréatologie et Oncologie Digestive - Beaujon
RECRUITINGClichy, 92110, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Service de Médecine Nucléaire, Groupe Hospitalier Bichat-Claude Bernard
ACTIVE_NOT_RECRUITINGParis, 75018, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
68Ga-DOTATOC PET-MRI imaging
What this could lead to
If successful, this could lead to better ways to predict which patients will benefit most from targeted radiation therapy for GEP-NETs.
What could go wrong
This is an observational imaging study, not a treatment trial. It may not directly improve outcomes, and results may not apply to all patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.